0001127602-12-028329.txt : 20121005 0001127602-12-028329.hdr.sgml : 20121005 20121005162440 ACCESSION NUMBER: 0001127602-12-028329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121003 FILED AS OF DATE: 20121005 DATE AS OF CHANGE: 20121005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAGEMANN ROBERT CENTRAL INDEX KEY: 0001222676 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 121132612 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-10-03 0001022079 QUEST DIAGNOSTICS INC DGX 0001222676 HAGEMANN ROBERT C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 SVP & Chief Financial Officer Common Stock 2012-10-03 4 M 0 46667 40.4275 A 201233 D Common Stock 2012-10-03 4 S 0 46667 64.00 D 154603 D Common Stock 1781 I SDCP Stock Options (Right to Buy) 40.4275 2012-10-03 4 M 0 46667 0 D 2014-02-19 Common Stock 46667 46667 D The exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 26, 2012. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date. The options vested in three annual installments on February 19, 2005, February 19, 2006 and February 19, 2007. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann 2012-10-05